Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2020 10:00 ET | Source: Vyriad

Vyriad Expands Clinical Study of Oncolytic Virus Therapy in Bladder Cancer Patients

ROCHESTER, Minn., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced today the addition of new clinical sites in its ongoing clinical study evaluating an intravesical oncolytic measles virus...
September 14, 2020 09:30 ET | Source: Vyriad

Imanis Life Sciences to Present IMMUNO-COV, a First-in-Class Neutralizing Antibody Test for COVID-19, at American Society of Gene and Cell Therapy Symposium

High-throughput clinical assay detects, quantifies SARS-CoV-2-neutralizing antibodies Imanis Life Sciences is an affiliate of Vyriad Inc. ROCHESTER, Minn., Sept. 14, 2020 (GLOBE NEWSWIRE) --...
July 20, 2020 10:00 ET | Source: Vyriad

Vyriad Announces Initiation of Phase 2 Trial in Multiple Cancer Indications

ROCHESTER, Minn., July 20, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced today the dosing of the first patient in a Phase 2 clinical trial to evaluate its investigational oncolytic virus...
May 29, 2020 07:30 ET | Source: Vyriad

Vyriad Inc. to Present Clinical Trial Updates for its Oncolytic Virotherapies at Virtual 2020 ASCO Annual Meeting

ROCHESTER, Minn., May 29, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced today that it will present data and information about the design of clinical trials evaluating its oncolytic viruses at the...
May 12, 2020 09:00 ET | Source: Vyriad

Vyriad Inc. Announces Development of a New Antibody Test to Determine Protective Immunity From COVID-19

Vyriad test detects SARS-CoV-2 virus-neutralizing antibodies Developed as part of an ongoing collaboration with Regeneron ROCHESTER, Minn., May 12, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced...